What You Should Know
Healthcare AI and utilization management technology company Xsolis announced the general availability of its GenAI Peer-to-Peer Clinical Synopsis solution.Directly addresses the critical 24- to 72-hour regulatory and commercial window for peer-to-peer denial reviews, giving physician advisors an instant, automated synthesis of medical necessity before speaking with health plan medical directors.Automatically scans the longitudinal electronic medical record (EMR) for vital
Read More
Weave Bio and Takeda Deploy AI Regulatory Automation Across 14 Global Programs
What You Should Know
AI-native regulatory software company Weave Bio announced a major enterprise collaboration with global biopharma leader Takeda to deploy its regulatory automation platform across 14 active drug development programs in multiple global markets.The collaboration directly addresses the heavy administrative bottleneck of regulatory dossier authoring, which has historically trapped critical scientific data inside static, hard-to-maintain document repositories.The system handled
Read More
PHTI Launches New Digital Diabetes Evaluation Centered on GLP-1s and CGMs
What You Should Know
The Peterson Health Technology Institute (PHTI) will conduct a comprehensive new independent evaluation of digital health tools for type 2 diabetes, slated for publication in 2027.The evaluation re-evaluates the market three years after its landmark March 2024 assessment, which determined that widely used digital diabetes tools relying on noncontinuous glucometers failed to deliver meaningful clinical improvements and drove up net healthcare spending.Focuses on the
Read More
GE HealthCare Expands Cardiovascular Ultrasound Portfolio with Vivid Explorer, Vivid Advanced, and Vivid Focus
What You Should Know
GE HealthCare unveiled three new cardiovascular ultrasound systems—Vivid™ Explorer, Vivid™ Advanced, and Vivid™ Focus—showcased at the European Society of Cardiology (ESC) Congress 2026 in Munich, Germany.All three systems leverage the software-defined cSound™ imaging architecture introduced on the ultra-premium Vivid Pioneer, standardizing image reconstruction, contrast, and spatial resolution across care environments. The systems pair with EchoPAC™ Software Only
Read More
Array Behavioral Care 2026 Report Reveals 95% Clinician Strain Amid False Capacity Confidence
What You Should Know
According to a nationwide survey released by Array Behavioral Care, 100% of hospital and health system leaders believe their behavioral health capacity meets or exceeds current demand, and 83% consider their models sustainable.Yet on the ground, 40% of those same administrators admit their facilities have turned away patients or instituted waitlists over the past year. The strain is acutely felt by clinical staff: 95% of surveyed clinicians report being forced to make
Read More
Intermountain Medical Center Deploys GE HealthCare’s AI-Powered SIGNA Sprint Elite MRI
What You Should Know
Intermountain Medical Center in Murray, Utah, is the first hospital in Utah—and only the second in the United States—to deploy GE HealthCare’s SIGNA Sprint Elite MRI system.GE HealthCare’s SIGNA Sprint Elite MRI system utilizes embedded artificial intelligence reconstruction software and advanced high-performance gradient hardware to reduce scan acquisition times and enhance diagnostic clarity for complex cardiovascular and oncologic conditions.
AI-Driven Clarity and
Read More
Transcarent Launches Bundled Payment Model for CAR T and BiTE Cancer Therapies Across Community Providers
What You Should Know
Transcarent launched a first-of-its-kind bundled payment model for bispecific T-cell engager (BiTE) and chimeric antigen receptor (CAR) T-cell therapies delivered through community oncology providers.Addresses the primary cost driver for self-insured employers: the Business Group on Health’s survey found that cancer is the No. 1 condition driving employer healthcare costs for the fifth consecutive year, with 70% of employers citing it as their top cost driver.Breakthrough
Read More
Abbott Receives FDA Authorization for Libre Duo 10 Day, World’s First Dual Glucose-Ketone Sensing System
What You Should Know
The U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization to Abbott for its Libre Duo 10 Day system, establishing the new integrated continuous glucose and ketone monitoring (iCGK) regulatory benchmark alongside standard iCGM status.Libre Duo monitors glucose and continuously tracks rising ketones in the background to prevent diabetic ketoacidosis (DKA), a critical emergency for which U.S. hospital admissions have increased by 55% over the
Read More
HIMSS Signs Historic MOUs at HIMSS26 APAC to Measure AI Value and Accelerate Malaysia’s ‘1 Person, 1 Record’
What You Should Know
At the HIMSS26 APAC Health Conference & Exhibition in Singapore (co-hosted with SingHealth), HIMSS executed two major Memorandums of Understanding (MOUs) and a national digital health maturity partnership.Establishes the HIMSS AI Outcomes Framework, the world’s first evidence-based, longitudinal standard for measuring the clinical, operational, and financial impact and ROI of healthcare artificial intelligence.Founding healthcare provider partners contributing
Read More
Fitbit Founders Unveil Luffu Link, Wearable for Family Health, Safety and Connection
What You Should Know
Fitbit co-founders James Park and Eric Friedman have officially unveiled Luffu Link, a screenless, jewelry-inspired LTE health and safety wearable designed specifically for family caregiving and aging in place.Luffu Link marks the first hardware device in a broader ecosystem spanning the Luffu smartphone app (introduced in February 2026 and currently in public beta), the wristband, and an upcoming dedicated in-home display device slated for later this year.Addresses the
Read More
